Financhill
Back

Novartis AG 10K Form

Buy
60

NVSEF
Novartis AG

Last Price:
$106.00
Seasonality Move:
-0.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVSEF News And Ratings

See the #1 stock for the next 7 days that we like better than NVSEF

NVSEF Financial Statistics

Sales & Book Value

Annual Sales: $51.7B
Cash Flow: $3.1B
Price / Cash Flow: 15.62
Annual Sales: $22.30
Price / Book: 4.75

Profitability

EPS (TTM): 5.88000
Net Income (TTM): $11.9B
Gross Margin: $38.9B
Return on Equity: 27.64%
Return on Assets: 12%

Novartis AG Earnings Forecast

Key Novartis AG Financial Ratios

  • The Gross Profit Margin over the past 27 years for NVSEF is 75.20%.
  • The Selling, General & Administrative Expenses for NVSEF have been equal to 24.30% of Gross Profit Margin.
  • The Research & Development expenses have been 19.38% of Revenue.
  • The Interest Expense is 8.42% of Operating Income.
  • The Net Earning history of NVSEF is 23.09% of Total Revenues.
  • Per Share Earnings over the last 27 years have been positive in 17 years.

Novartis AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: NVSEF
Website: novartis.com

Debt

Debt-to-Equity Ratio: 0.67
Current Ratio: 1.04
Quick Ratio: 0.8

Price-to-Earnings

Trailing P/E Ratio: 18.06
Forward P/E Ratio: 0

NVSEF Technical Analysis vs Fundamental Analysis

Buy
60
Novartis AG (NVSEF) is a Buy

Is Novartis AG a Buy or a Sell?

  • Novartis AG stock is rated a Buy
    The current Novartis AG [NVSEF] share price is $106.00. The Score for NVSEF is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.